je.st
news
Tag: trials
Ebola buster booster vaccine starts first trials in Oxford
2014-12-04 15:35:33| Biotech - Topix.net
Scientists at Oxford University have launched the first clinical tests of a new Ebola vaccine approach, using a booster developed by Denmark's Bavarian Nordic that may improve the effects of a shot from GlaxoSmithKline. Thirty healthy volunteers in Britain who have already received the experimental Ebola vaccine being developed by GSK and the US National Institutes of Health will get the booster shot, researchers said on Thursday.
Tags: starts
oxford
trials
booster
RAN helicopters begin deck handling trials on HMAS Canberra
2014-12-02 01:00:00| Naval Technology
Royal Australian Navy helicopters have started the initial phase of deck handling trials on the newly commissioned HMAS Canberra, marking the beginning of the Naval Operational Test and Evaluation programme.
Tags: begin
handling
ran
trials
MWV's MEMS System chosen for trials of HIV-prevention medication in Africa and India
2014-12-02 00:21:46| Paper - Topix.net
MeadWestvaco Corporation , a global leader in packaging and packaging solutions , has received a grant to provide its Medication Event Monitoring System to The Bill & Melinda Gates Foundation. The system is being used in the foundation's new demonstration projects on pre-exposure prophylaxis medications to help prevent the spread of HIV/AIDS in sub-Saharan Africa and India.
Tags: system
india
africa
chosen
Giraffic announces MPEG-DASH client trials
2014-11-20 15:30:44| Digital TV News
Giraffic has announced trials of its Adaptive Video Acceleration (AVA) for MPEG-DASH. AVA is a client-side network throughput optimization technology that offers consumers HD video without re-buffering pauses or reliance on streaming resolution reduction technology.
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials
2014-11-19 04:46:13| Biotech - Topix.net
CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced that the Company has received notice from the United States Food and Drug Administration that its clinical trials for aldoxorubicin have been placed on partial clinical hold. All currently enrolled patients can continue receiving aldoxorubicin treatment, or comparator drugs, as per study protocols, but no new patients can be enrolled until the clinical hold is lifted.
Tags: hold
clinical
partial
affecting
Sites : [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] next »